Physician profile
Judith K Wright
NPI 1295069474
$5,032.29
in general payments reported to CMS, 2019-2025
24 companies · $980 in 2025
The $980 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,034 · 2022: $839 · 2023: $1,196 · 2024: $984 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,159.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $821.32 | 2021-2024 | Watchman Access System, Watchman Flx, Bodyguardian |
| Novartis Pharmaceuticals Corporation | $670.22 | 2021-2025 | |
| Amgen INC. | $489.78 | 2021-2025 | Repatha, Repatha |
| Novo Nordisk INC | $390.79 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $376.23 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $356.50 | 2021-2024 | Xarelto |
| Pfizer INC. | $307.35 | 2021-2025 | |
| Altathera Pharmaceuticals LLC | $280.23 | 2023 | Sotalol Hydrochloride |
| Esperion Therapeutics, INC. | $187.36 | 2021-2025 | Nexletol |
| Impulse Dynamics (USA) INC. | $166.93 | 2023-2024 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals Lp | $165.24 | 2021-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.36 | 2022-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $134.04 | 2023-2025 | Verquvo |
| United Therapeutics Corporation | $125.00 | 2021 | |
| Medtronic, INC. | $112.89 | 2025 | Corevalve Evolut R |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $70.85 | 2021-2022 | |
| Agepha Pharma Fz LLC | $53.83 | 2024-2025 | Lodoco |
| Althera Pharmaceuticals LLC | $44.42 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $28.21 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $23.36 | 2021 | |
| Abbott Laboratories | $23.18 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.73 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.13 | 2025 | |
| Scpharmaceuticals INC. | $13.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.